The association of paraoxonase I gene polymorphisms Q192R (rs662) and L55M (rs854560) and its activity with metabolic syndrome components in fars ethnic group

Horm Mol Biol Clin Investig. 2023 Feb 17;44(3):295-303. doi: 10.1515/hmbci-2022-0064. eCollection 2023 Sep 1.

Abstract

Objectives: Metabolic syndrome (MetS) may cause premature development of some diseases. PON1 genes may be involved in the pathogenesis of MetS. The aim of study was to evaluate the association between Q192R and L55M gene polymorphisms and its enzyme activity with the MetS components in subjects with and without MetS.

Methods: Polymerase Chain Reaction and Restriction Fragment Length Polymorphism analysis were performed to determine polymorphisms of the paraoxonase1 gene in subjects with and without metabolic syndrome. Biochemical parameters were measured by spectrophotometer.

Results: The MM, LM, and LL genotype frequencies of the PON1 L55M polymorphism were 10.5, 43.4, and 46.1%, and 22.4, 46.6, and 31% and; the QQ, QR, and RR genotype frequencies of the PON1 Q192R polymorphism were 55.4, 38.6 and 6%; and 56.5, 34.8 and 8.7% in subjects with and without MetS, respectively. The L and M allele frequencies were 68 and 53%; and 32 and 47% for PON1 L55M in subjects with and without MetS, respectively. The Q and R allele frequencies for PON1 Q192R were 74 and 26% in both groups. There were significant differences in HDL-cholesterol level and PON1 activity in the genotypes QQ, QR, and RR of the PON1 Q192R polymorphism in subjects with MetS.

Conclusions: The PON1 Q192R genotypes had only effected on PON1 activity and HDL-cholesterol level in subjects with MetS. Different genotypes of the PON1 Q192R seem to be important candidates to make the subjects susceptible to MetS in the Fars ethnic group.

Keywords: activity; fars ethnic; metabolic syndrome; paraoxonase 1; polymorphism.

MeSH terms

  • Aryldialkylphosphatase* / genetics
  • Aryldialkylphosphatase* / metabolism
  • Cholesterol
  • Ethnicity / genetics
  • Genetic Predisposition to Disease
  • Humans
  • Metabolic Syndrome* / genetics
  • Polymorphism, Genetic

Substances

  • Aryldialkylphosphatase
  • Cholesterol
  • PON1 protein, human